Market Closed

PYXS
Pyxis Oncology
$ 1.58
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Pyxis Oncology News

Latest Pyxis Oncology Stock News & PYXS Headlines

Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)
10 days ago | globenewswire.com
Pyxis Oncology to Participate in Upcoming Investor Conferences
18 days ago | globenewswire.com
Pyxis Oncology (NASDAQ:PYXS) & Precigen (NASDAQ:PGEN) Head to Head Analysis
a month ago | defenseworld.net
Pyxis Oncology: Better Runway Is Bullish For MICVO's Remaining R&D
a month ago | seekingalpha.com
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
a month ago | globenewswire.com
Critical Survey: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)
a month ago | defenseworld.net
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
2 months ago | globenewswire.com
Pyxis Oncology Announces Proposed Public Offering
2 months ago | globenewswire.com
Critical Analysis: Pyxis Oncology (NASDAQ:PYXS) vs. ProKidney (NASDAQ:PROK)
2 months ago | defenseworld.net
Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell Carcinoma Transcript
2 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

PYXS
Pyxis Oncology
$ 1.58
0.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago